A Phase 2b study of brivekimig in moderate to severe hidradenitis suppurativa

Recruiting Phase 2 NCT07170917

Study Description

A research study testing different doses of an investigational medication called brivekimig for people with moderate to severe hidradenitis suppurativa

Study Details

Registry ID:: NCT07170917
Conditions:: Hidradenitis Suppurativa
Phase:: Phase 2
Target Enrollment:: 208 participants
Start Date:: November 6, 2025
Healthy Volunteers:: No

Study Locations (83 sites)

Investigational Site Number: 7240003
Las Palmas de Gran Canaria, Las PalmasSpain, Spain
Investigational Site Number: 7240004
CadizSpain, Spain
Investigational Site Number : 7240007
GranadaSpain, Spain
Investigational Site Number: 7240002
Manises, ValenciaSpain, Spain
Investigational Site Number : 3800001
CataniaItaly, Italy
Investigational Site Number: 7240001
MadridSpain, Spain
Investigational Site Number: 7240005
MadridSpain, Spain
Investigational Site Number: 2500007
ToulouseFrance, France
Investigational Site Number: 7240006
Santiago de Compostela, A Coruña [La Coruña]Spain, Spain
Investigational Site Number : 3000001
AthensGreece, Greece
Investigational Site Number : 3000002
AthensGreece, Greece
Investigational Site Number : 3000005
AthensGreece, Greece
Investigational Site Number : 2500003
BordeauxFrance, France
Investigational Site Number : 2500006
Saint-Priest-en-JarezFrance, France
Investigational Site Number : 2500002
LyonFrance, France
Istituto Dermatologico San Gallicano, IRCCS - Site Number : 3800004
RomaItaly, Italy
Investigational Site Number : 3800004
RomaItaly, Italy
Investigational Site Number: 3800002
Milan, MilanoItaly, Italy
Investigational Site Number : 3000004
ThessalonikiGreece, Greece
Investigational Site Number: 3760001
Tel AvivIsrael, Israel
Investigational Site Number: 3760002
JerusalemIsrael, Israel
Investigational Site Number : 3760003
HaifaIsrael, Israel
Investigational Site Number: 2500001
AntonyFrance, France
Investigational Site Number: 2500004
BezannesFrance, France
Investigational Site Number: 3480003
PécsHungary, Hungary
Investigational Site Number : 3480004
SzékesfehérvárHungary, Hungary
Investigational Site Number : 2760004
MainzGermany, Germany
Investigational Site Number : 2760006
WürzburgGermany, Germany
Investigational Site Number : 2760003
FrankfurtGermany, Germany
Investigational Site Number : 8260008
London, EnglandUnited Kingdom, United Kingdom
Investigational Site Number : 2760002
BochumGermany, Germany
Investigational Site Number: 2030004
PragueCzechia, Czechia
Investigational Site Number: 2030001
PragueCzechia, Czechia
Site Number: 3480001
Debrecen, Gangwon-doHungary, Hungary
Investigational Site Number : 2760001
MünsterGermany, Germany
Investigational Site Number : 2760008
BramscheGermany, Germany
Investigational Site Number: 2030003
OstravaCzechia, Czechia
Investigational Site Number: 2030002
OstravaCzechia, Czechia
Investigational Site Number : 5280002
GroningenNetherlands, Netherlands
Investigational Site Number : 8260006
LeedsUnited Kingdom, United Kingdom
Investigational Site Number: 6160001
Wroclaw, Lower Silesian VoivodeshipPoland, Poland
Investigational Site Number : 2760005
KielGermany, Germany
Investigational Site Number: 6160003
Lodz, LódzkiePoland, Poland
Investigational Site Number: 6160002
Warsaw, Masovian VoivodeshipPoland, Poland
Investigational Site Number : 7840001
Abu DhabiUnited Arab Emirates, United Arab Emirates
Grupo Dermatologico de Carolina- Site Number : 8400023
CarolinaPuerto Rico, Puerto Rico
Investigational Site Number: 1520005
Santiago, Reg Metropolitana de SantiagoChile, Chile
Investigational Site Number: 1520001
Santiago, Reg Metropolitana de SantiagoChile, Chile
Investigational Site Number: 1520002
Santiago, Reg Metropolitana de SantiagoChile, Chile
Investigational Site Number: 1520003
Santiago, Reg Metropolitana de SantiagoChile, Chile
Clinical Partners- Site Number : 8400002
Johnston, Rhode IslandUnited States, United States
FXM Clinical Research - Miami- Site Number : 8400017
Miami, FloridaUnited States, United States
FXM Clinical Research Miramar, LLC - Site Number: 8400004
Miramar, FloridaUnited States, United States
FXM Clinical Research - Miramar- Site Number : 8400004
Miramar, FloridaUnited States, United States
Investigational Site Number: 1240005
Québec, QuebecCanada, Canada
AMR Clinical South Strand, South Carolina- Site Number : 8400018
Myrtle Beach, South CarolinaUnited States, United States
AMR Clinical Research – South Strand
Myrtle Beach, South CarolinaUnited States, United States
Georgia Skin & Cancer Clinic- Site Number : 8400009
Savannah, GeorgiaUnited States, United States
Investigational Site Number : 1240009
Toronto, OntarioCanada, Canada
Lima's Excellence in Allergy and Dermatology Research (LEADER) Inc.
Hamilton, OntarioCanada, Canada
Advanced Medical Research - Atlanta- Site Number : 8400011
Atlanta, GeorgiaUnited States, United States
Louisiana Dermatology Associates- Site Number : 8400006
Baton Rouge, LouisianaUnited States, United States
Investigational Site Number : 1560005
ÜrümqiChina, China
Washington University- Site Number : 8400010
St Louis, MissouriUnited States, United States
UT Southwestern Medical Center, Department of Dermatology- Site Number : 8400022
Dallas, TexasUnited States, United States
The Iowa Clinic West Des Moines Campus- Site Number : 8400007
West Des Moines, IowaUnited States, United States
Investigational Site Number : 1560002
ChengduChina, China
Investigational Site Number : 1560001
GuangzhouChina, China
Mayo Clinic in Arizona - Scottsdale- Site Number : 8400014
Scottsdale, ArizonaUnited States, United States
Medical Dermatology Specialists - Site Number: 8400019
Phoenix, ArizonaUnited States, United States
Alpine Research Association- Site Number : 8400008
Layton, UtahUnited States, United States
JDR Dermatology Research - Site number: 8400012
Las Vegas, NevadaUnited States, United States
Northridge Clinical Trials - Northridge- Site Number : 8400005
Northridge, CaliforniaUnited States, United States
Park Dermatology - Site number: 1240007
Sherwood ParkCanada, Canada
Investigational Site Number : 1560004
ShanghaiChina, China
Investigational Site Number : 1240008
Edmonton, AlbertaCanada, Canada
Interior Dermatology Centre - Site Number: 1240003
Kelowna, British ColumbiaCanada, Canada
University of the Ryukyus Hospital - Site Number: 3920002
Nishihara, OkinawaJapan, Japan
University of the Ryukyus Hospital - Site Number: 3920002
Ginowan, OkinawaJapan, Japan
Meiwa Hospital
Nishinomiya-shiJapan, Japan
Nihon University Itabashi Hospital
TokyoJapan, Japan
Alfred Hospital - Site Number: 0360002
Melbourne, VictoriaAustralia, Australia
Investigational Site Number: 0360001
Liverpool, New South WalesAustralia, Australia

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.org.

View full study details and check eligibility →